1. Home
  2. CFFN vs CTMX Comparison

CFFN vs CTMX Comparison

Compare CFFN & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capitol Federal Financial Inc.

CFFN

Capitol Federal Financial Inc.

HOLD

Current Price

$7.56

Market Cap

981.1M

Sector

Finance

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.62

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFN
CTMX
Founded
1893
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
981.1M
977.1M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
CFFN
CTMX
Price
$7.56
$3.62
Analyst Decision
Hold
Strong Buy
Analyst Count
2
10
Target Price
$7.25
$12.10
AVG Volume (30 Days)
869.4K
2.9M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
4.51%
N/A
EPS Growth
79.31
N/A
EPS
0.32
N/A
Revenue
$16,300,000.00
$76,201,000.00
Revenue This Year
$20.16
N/A
Revenue Next Year
$6.62
$7.61
P/E Ratio
$23.80
$22.58
Revenue Growth
6.54
N/A
52 Week Low
$5.51
$1.72
52 Week High
$7.97
$8.21

Technical Indicators

Market Signals
Indicator
CFFN
CTMX
Relative Strength Index (RSI) 46.51 30.72
Support Level $7.47 $3.39
Resistance Level $7.85 $3.91
Average True Range (ATR) 0.16 0.21
MACD -0.04 -0.04
Stochastic Oscillator 17.00 5.63

Price Performance

Historical Comparison
CFFN
CTMX

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: